Carla Emiliani Selected Research

delta(6)-hexadecenoic acid

4/2020

The n-10 Fatty Acids Family in the Lipidome of Human Prostatic Adenocarcinoma Cell Membranes and Extracellular Vesicles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla Emiliani Research Topics

Disease

11	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2020 - 10/2003
8	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 10/2003
6	Neoplasms (Cancer) 12/2020 - 05/2009
4	Sandhoff Disease (Sandhoff's Disease) 03/2022 - 11/2005
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 03/2022 - 04/2015
3	Parkinson Disease (Parkinson's Disease) 04/2020 - 11/2009
3	GM2 Gangliosidoses (GM2 Gangliosidosis) 06/2019 - 06/2002
2	Neuroblastoma 03/2019 - 05/2016
2	Tuberous Sclerosis (Bourneville's Disease) 05/2018 - 01/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 08/2014
2	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2014 - 05/2005
1	Metabolic Diseases (Metabolic Disease) 03/2022
1	Gliosis 01/2022
1	Globoid Cell Leukodystrophy (Krabbe Disease) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Drug-Induced Abnormalities (Abnormalities, Drug Induced) 11/2021
1	COVID-19 06/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Inflammation (Inflammations) 09/2020
1	Parkinsonian Disorders (Parkinsonism) 04/2020
1	Adenocarcinoma 04/2020
1	Autoimmune Diseases (Autoimmune Disease) 08/2019
1	Central Nervous System Cavernous Hemangioma 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Pathologic Processes 06/2018
1	Neurologic Manifestations (Neurological Manifestations) 05/2018
1	Carcinogenesis 05/2018
1	Cysts 10/2017
1	Cognitive Dysfunction 08/2017
1	Persistent Infection 06/2017
1	Astrocytoma (Pilocytic Astrocytoma) 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Clinical Deterioration 04/2015
1	Sphingolipidoses (Sphingolipidosis) 08/2014
1	Prostatic Neoplasms (Prostate Cancer) 06/2014
1	Starvation 04/2013
1	Malaria 01/2012
1	Infections 01/2012

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2008
6	EnzymesIBA 03/2022 - 06/2002
5	LipidsIBA 01/2022 - 01/2015
4	Hexosaminidases (Hexosaminidase)IBA 01/2015 - 11/2005
3	Biological ProductsIBA 01/2022 - 05/2016
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 03/2013
3	Glycoside Hydrolases (Endoglycosidases)IBA 03/2019 - 10/2003
3	TOR Serine-Threonine KinasesIBA 01/2019 - 05/2016
3	beta-N-AcetylhexosaminidasesIBA 02/2010 - 06/2002
2	PolymersIBA 03/2022 - 01/2019
2	Hexosaminidase A (Hex A)IBA 03/2022 - 06/2014
2	poly(lactide) (polylactic acid)IBA 03/2022 - 04/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 12/2020
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2019
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2020 - 04/2020
2	RotenoneIBA 04/2020 - 07/2019
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 05/2016
2	MTOR InhibitorsIBA 01/2019 - 05/2016
2	trans-sodium crocetinate (crocetin)IBA 05/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2018 - 01/2017
2	G(M2) Ganglioside (Ganglioside GM2)IBA 08/2014 - 11/2005
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2014 - 05/2005
1	secukinumabIBA 01/2022
1	Adalimumab (Humira)FDA Link 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	GalactosylceramidaseIBA 01/2022
1	LithiumIBA 01/2022
1	Psychosine (Galactosylsphingosine)IBA 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2021
1	Membrane LipidsIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	ApolipoproteinsIBA 09/2020
1	Amyloid (Amyloid Fibrils)IBA 09/2020
1	AntioxidantsIBA 04/2020
1	Protein AggregatesIBA 04/2020
1	CurcuminIBA 04/2020
1	delta(6)-hexadecenoic acidIBA 04/2020
1	VaccinesIBA 08/2019
1	NeurotoxinsIBA 07/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	GlycosphingolipidsIBA 03/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 06/2018
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2017
1	Cysteine Proteases (Cysteine Protease)IBA 06/2017
1	alpha-Glucosidases (Acid Maltase)IBA 04/2015
1	GlycogenIBA 04/2015
1	AcidsIBA 04/2015
1	GangliosidesIBA 01/2015
1	GalactosidasesIBA 01/2015
1	Pyrimethamine (Daraprim)FDA Link 08/2014
1	SphingolipidsIBA 08/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	IsoenzymesIBA 06/2014
1	CeramidesIBA 01/2014
1	Transfer RNA (tRNA)IBA 04/2013
1	Amino Acids FDA Link 04/2013
1	ParaquatIBA 11/2009
1	TubulinIBA 05/2009

Therapy/Procedure

4	Therapeutics 01/2019 - 08/2014